Titration Plan (Once Daily) Gradual titration on a 20 mg blend reconstituted with 3.0 mL BAC water Week Weeks 1-2 Dose (each peptide) 100 mcg Insulin units 3 units Volume 0.03 mL Week Weeks 3-4 Dose (each peptide) 150 mcg Insulin units 4.5 units Volume 0.045 mL Week Weeks 5-8 Dose (each peptide) 200 mcg Insulin units 6 units Volume 0.06 mL Week Weeks 9-12 Dose (each peptide) 200-300 mcg Insulin units 6-9 units Volume 0.06-0.09 mL These are research-planning ranges drawn from common protocol summaries (Teichman 2006 dosing studied CJC-1295 with DAC, not no-DAC)
Xeomin differs from Botox in that it contains no accessory proteins
If you have any health conditions, pregnancy, allergies, or any contraindications to treatments or ingredients, please let our front desk know ahead of time so we can customize the best treatment possible for you.
Once inflammation subsides, we guide you through safe, targeted movements to strengthen supporting muscles and restore natural biomechanicspreventing recurrence
AOD-9604's entire human trial program involved 893 participants across six studies, with the largest being the 536-subject Phase 2b trial that failed to meet its endpoint
[DOI] [PubMed] [Google Scholar] 47.Van Schooten F.J., Besaratina A., De Flora S., Dagostina F., Izzotti A., Camoirano A., Balm A.J., Dallinga J.W., Bast A., Haenen G.R., et al
